Overview

A Safety and Effectiveness Study of Golimumab in Japanese Patients With Moderately to Severely Active Ulcerative Colitis.

Status:
Completed
Trial end date:
2016-01-29
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate safety and effectiveness of golimumab in Japanese participants with moderately to severely active ulcerative colitis.
Phase:
Phase 3
Details
Lead Sponsor:
Janssen Pharmaceutical K.K.
Treatments:
Antibodies, Monoclonal
Golimumab